Compare NEOG & PX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEOG | PX |
|---|---|---|
| Founded | 1981 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1989 | 2021 |
| Metric | NEOG | PX |
|---|---|---|
| Price | $7.03 | $9.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $8.83 | ★ $15.70 |
| AVG Volume (30 Days) | ★ 3.4M | 455.5K |
| Earning Date | 01-08-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 1.53% |
| EPS Growth | N/A | ★ 35.89 |
| EPS | N/A | ★ 0.14 |
| Revenue | ★ $886,886,000.00 | $301,314,000.00 |
| Revenue This Year | N/A | $2.80 |
| Revenue Next Year | $1.80 | $18.77 |
| P/E Ratio | ★ N/A | $71.49 |
| Revenue Growth | N/A | ★ 9.77 |
| 52 Week Low | $3.87 | $8.68 |
| 52 Week High | $13.41 | $13.93 |
| Indicator | NEOG | PX |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 48.14 |
| Support Level | $7.01 | $9.71 |
| Resistance Level | $7.29 | $10.15 |
| Average True Range (ATR) | 0.25 | 0.25 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 41.19 | 27.82 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue primarily comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.